@article{ref1,
title="Determinants of three-year clinical outcomes in real-world outpatients with bipolar disorder: The multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics (MUSUBI)",
journal="Journal of psychiatric research",
year="2022",
author="Katsumoto, Eiichi and Edagawa, Koji and Goto, Eiichiro and Hongo, Seiji and Shimoda, Kazutaka and Watanabe, Koichiro and Tsuboi, Takashi and Kikuchi, Toshiaki and Nakagawa, Atsuo and Yoshimura, Reiji and Kato, Masaki and Ueda, Hitoshi and Yasui-Furukori, Norio and Azekawa, Takaharu and Miki, Kazuhira and Watanabe, Yoichiro and Kubota, Yukihisa and Adachi, Naoto and Sugawara, Norio",
volume="151",
number="",
pages="683-692",
abstract="BACKGROUND: There is limited evidence regarding predictors of long-term clinical outcomes in patients with bipolar disorder (BD). The objective of this study was to describe 3-year clinical outcomes and identify their predictors from participants in the multicenter treatment survey for BD in psychiatric outpatient clinics (MUSUBI). <br><br>METHODS: The MUSUBI was a naturalistic study investigating patients with BD in real-world clinical practice. Our study extracted data regarding 1647 outpatients with BD from 2016, 2017, and 2019 as baseline, 1-year, and 3-year assessments. As clinical outcomes, we assessed the presence of time ill (depressive and manic) during the 1 year prior to the 3-year assessment and durable remission (53 weeks or more) prior to the 3-year assessment. <br><br>RESULTS: Participants with durable remission prior to the 3-year assessment had significant associations with diagnosis of a personality disorder and duration of continuous remission at baseline. Regarding the presence of depressive symptoms during the 1 year prior to the 3-year assessment, work status, Global Assessment of Functioning (GAF) scores, suicidal ideation, and duration of continuous remission at baseline had significant associations with this outcome. <br><br>CONCLUSIONS: At the 3-year assessment, 19.3% of participants (318/1647) achieved durable remission, while 47.5% of them (782/1647) were not remitted. Our findings can help clinicians predict the illness course of BD by understanding demographic and clinical characteristics.<p /><p>Language: en</p>",
language="en",
issn="0022-3956",
doi="10.1016/j.jpsychires.2022.05.028",
url="http://dx.doi.org/10.1016/j.jpsychires.2022.05.028"
}